Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Breaking: Well Pharmacy joins Oxford trial for Covid-19 treatment to raise awareness

Well Pharmacy has teamed up with an Oxford university trial for coronavirus treatment to support its most vulnerable and at-risk patients and members of staff.

The independent pharmacy chain is helping fight Covid-19 by supporting the PRINCIPLE trial, one of the UK’s four national priority platform trials on the disease.


The PRINCIPLE trial looks at evaluating the use of commonly used antibiotics in the treatment of coronavirus within the community and is endorsed by the chief medical officers of the four UK nations.

It is a nationwide clinical trial from the University of Oxford for the over-50s and aims to slow or halt the early progression of Covid-19 and prevent the need for hospital admission.

Working closely with Prof Mahendra Patel, the national BAME community and pharmacy lead at PRINCIPLE, Well will reach out to the communities it serves and publicise the trial through its website in order to help recruit people aged 50 and over with underlying health conditions, or everyone aged over 65, into the trial via the company’s 750 pharmacies up and down the UK.

Welcoming The UK’s largest independent pharmacy chain aboard, Prof Patel said: “Pharmacy teams are firmly embedded within the hearts of many communities throughout the UK and play an important role in improving public health and reducing health inequalities.

"So not surprisingly I am absolutely delighted to have Well Pharmacy on board in supporting this important work and the fight against Covid-19 pandemic, which disproportionately affects some more than others.”

Regardless of where people live in the UK, those with coronavirus symptoms can be pre-screened for eligibility by the PRINCIPLE team in the comfort of their own home. The team from Oxford will monitor the symptoms of those recruited for a period of 28 days and all information, including treatment, will be couriered to the homes of those participating. There will be no need for any face-to-face contact.

Janice Perkins, pharmacy superintendent at Well, said: “Supporting and promoting this vital research to our patients and customers across the thousands of local communities we serve, is enormously important to us.

"We want to do all we can to help slow or halt the progression of Covid-19, particularly supporting those aged 50 and our BAME communities who are more vulnerable during these difficult times.

"I would urge any of our customers and patients or their family and friends who may be affected by Covid-19 and are eligible, to contact us and take part in this trial.”

Well Pharmacy told Pharmacy Business today (Oct 17) that it would be raising awareness of the trial and reaching out to the wider communities it serves throughout UK.

More For You

Cancer patients warned against using weight-loss jabs

Macmillan Cancer Support said there is not enough evidence on how the weight-loss jabs might affect anti-cancer treatments.

iStock

Cancer patients warned against using weight-loss jabs

Cancer patients have been advised to consult their doctor before taking any weight-loss jabs.

Macmillan Cancer Support has issued this advisory following a surge in calls by cancer patients asking whether they can take fat loss jabs such as Wegovy and Mounjaro.

Keep ReadingShow less
Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology

The FLOWRx auto hub in the new Kamson warehouse in Uckfield.

Kamson Pharmacy to deliver more clinical services after installing hub and spoke technology


Kamsons Pharmacy has announced that it has implemented a state-of-the-art hub and spoke dispensing model with the aim of freeing up more time to deliver clinical services.

Keep ReadingShow less
RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less
Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less